Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter In the news 22 Feb 2023 Read More
Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin as CEO and Lindsay Edwards as CTO In the news 09 Jun 2022 Read More
Endpoints Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D In the news 09 Jun 2022 Read More
First Wave of Startups Harnesses UK’s Most Powerful Supercomputer to Power Digital Biology Breakthroughs In the news 22 Mar 2022 Read More
Utilizing graph machine learning within drug discovery and development Scientific publication 01 Nov 2021 Read More
Relation Therapeutics teams up with Mila in coalition to identify COVID-19 therapeutic candidates In the news 01 Sep 2020 Read More